As India edged nearer to full membership of the World Trade Organisation in 2005, Indian pharmaceutical companies faced new realities. For Ranbaxy Laboratories, a major player in the Indian generic drugs market, a successful adaptation to life in this new market was key to the company’s future. This case, Ranbaxy Laboratories Limited: At the Crossroads by Amitava Chattopadhyay and Swati Srivastava examines one company facing choices in one of the fastest growing sectors of the Indian economy.
Authors: Amitava Chattopadhyay, Swati Srivastava
Subjects: Industry Specific, International
Company: Ranbaxy Laboratories Limited